{"id":"https://openalex.org/W7124728604","doi":"https://doi.org/10.22159/ijap.2026v18i1.56285","title":"DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR THE QUANTIFICATION OF REPOTRECTINIB IN HUMAN PLASMA","display_name":"DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR THE QUANTIFICATION OF REPOTRECTINIB IN HUMAN PLASMA","publication_year":2026,"publication_date":"2026-01-07","ids":{"openalex":"https://openalex.org/W7124728604","doi":"https://doi.org/10.22159/ijap.2026v18i1.56285"},"language":"en","primary_location":{"id":"doi:10.22159/ijap.2026v18i1.56285","doi":"https://doi.org/10.22159/ijap.2026v18i1.56285","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2026v18i1.56285","pdf_url":"https://journals.innovareacademics.in/index.php/ijap/article/download/56285/33170","source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journals.innovareacademics.in/index.php/ijap/article/download/56285/33170","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5146683842","display_name":"VASUDEVA RAO BOBBA","orcid":"https://orcid.org/0009-0009-1701-3514","observed_orcids":["https://orcid.org/0009-0009-1701-3514"]},"institutions":[{"id":"https://openalex.org/I100887729","display_name":"Andhra University","ror":"https://ror.org/049skhf47","country_code":"IN","type":"education","lineage":["https://openalex.org/I100887729"]},{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"VASUDEVA RAO BOBBA","raw_affiliation_strings":["Analytical Research Department, Apitoria Research Centre, Aurobindo Pharma Limited, Hyderabad-502329, Telangana, India. Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam-530003, Andhra Pradesh, India"],"raw_orcid":"https://orcid.org/0009-0009-1701-3514","affiliations":[{"raw_affiliation_string":"Analytical Research Department, Apitoria Research Centre, Aurobindo Pharma Limited, Hyderabad-502329, Telangana, India. Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam-530003, Andhra Pradesh, India","institution_ids":["https://openalex.org/I100887729","https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074937874","display_name":"M. Padma","orcid":"https://orcid.org/0000-0001-6213-1549","observed_orcids":["https://orcid.org/0000-0001-6213-1549"]},"institutions":[{"id":"https://openalex.org/I100887729","display_name":"Andhra University","ror":"https://ror.org/049skhf47","country_code":"IN","type":"education","lineage":["https://openalex.org/I100887729"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"MOGILI PADMA","raw_affiliation_strings":["Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam-530003, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam-530003, Andhra Pradesh, India","institution_ids":["https://openalex.org/I100887729"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090970989","display_name":"Vundavilli Jagadeesh Kumar","orcid":"https://orcid.org/0000-0003-3798-2506","observed_orcids":["https://orcid.org/0000-0003-3798-2506"]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"VUNDAVILLI JAGADEESH KUMAR","raw_affiliation_strings":["Analytical Research Department, Apitoria Research Centre, Aurobindo Pharma Limited, Hyderabad-502329, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Research Department, Apitoria Research Centre, Aurobindo Pharma Limited, Hyderabad-502329, Telangana, India","institution_ids":["https://openalex.org/I4210110833"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.678,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.75548902,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"193","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.05739999935030937,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/repotrectinib","display_name":"repotrectinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lc-ms-ms-method-development","display_name":"LC-MS/MS method development","score":0.7639999985694885},{"id":"https://openalex.org/keywords/human-plasma-quantification","display_name":"human plasma quantification","score":0.7509999871253967},{"id":"https://openalex.org/keywords/bioanalytical-method-validation","display_name":"bioanalytical method validation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/matrix-effects","display_name":"matrix effects","score":0.6610000133514404},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7689999938011169},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7045000195503235},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.6159999966621399},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.574999988079071},{"id":"https://openalex.org/C2777379063","wikidata":"https://www.wikidata.org/wiki/Q161233","display_name":"Formic acid","level":2,"score":0.5539000034332275},{"id":"https://openalex.org/C2780092901","wikidata":"https://www.wikidata.org/wiki/Q3433612","display_name":"Correlation coefficient","level":2,"score":0.5343999862670898},{"id":"https://openalex.org/C48921125","wikidata":"https://www.wikidata.org/wiki/Q10861030","display_name":"Linear regression","level":2,"score":0.516700029373169},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.45809999108314514},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4332999885082245},{"id":"https://openalex.org/C138268822","wikidata":"https://www.wikidata.org/wiki/Q1051925","display_name":"Resolution (logic)","level":2,"score":0.40459999442100525},{"id":"https://openalex.org/C128990827","wikidata":"https://www.wikidata.org/wiki/Q192830","display_name":"Coefficient of determination","level":2,"score":0.3896999955177307},{"id":"https://openalex.org/C202799725","wikidata":"https://www.wikidata.org/wiki/Q272035","display_name":"Accuracy and precision","level":2,"score":0.3874000012874603},{"id":"https://openalex.org/C106487976","wikidata":"https://www.wikidata.org/wiki/Q685816","display_name":"Matrix (chemical analysis)","level":2,"score":0.38519999384880066},{"id":"https://openalex.org/C2777463227","wikidata":"https://www.wikidata.org/wiki/Q408047","display_name":"Acetonitrile","level":2,"score":0.383899986743927},{"id":"https://openalex.org/C187428577","wikidata":"https://www.wikidata.org/wiki/Q898396","display_name":"Ionic strength","level":3,"score":0.3732999861240387},{"id":"https://openalex.org/C9893847","wikidata":"https://www.wikidata.org/wiki/Q1425625","display_name":"Reproducibility","level":2,"score":0.3400000035762787},{"id":"https://openalex.org/C172120300","wikidata":"https://www.wikidata.org/wiki/Q1134348","display_name":"Volumetric flow rate","level":2,"score":0.3310000002384186},{"id":"https://openalex.org/C2989041947","wikidata":"https://www.wikidata.org/wiki/Q186290","display_name":"Linear correlation","level":2,"score":0.319599986076355},{"id":"https://openalex.org/C3019152653","wikidata":"https://www.wikidata.org/wiki/Q186290","display_name":"Linear relationship","level":2,"score":0.31520000100135803},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.2651999890804291},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.2615000009536743},{"id":"https://openalex.org/C2182769","wikidata":"https://www.wikidata.org/wiki/Q62500","display_name":"Ionic bonding","level":3,"score":0.2556999921798706},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.2556999921798706}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22159/ijap.2026v18i1.56285","doi":"https://doi.org/10.22159/ijap.2026v18i1.56285","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2026v18i1.56285","pdf_url":"https://journals.innovareacademics.in/index.php/ijap/article/download/56285/33170","source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22159/ijap.2026v18i1.56285","doi":"https://doi.org/10.22159/ijap.2026v18i1.56285","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ijap.2026v18i1.56285","pdf_url":"https://journals.innovareacademics.in/index.php/ijap/article/download/56285/33170","source":{"id":"https://openalex.org/S2764477652","display_name":"International Journal of Applied Pharmaceutics","issn_l":"0975-7058","issn":["0975-7058"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Applied Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7124728604.pdf","grobid_xml":"https://content.openalex.org/works/W7124728604.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1963766061","https://openalex.org/W1979401615","https://openalex.org/W2110353553","https://openalex.org/W2984143136","https://openalex.org/W2995313454","https://openalex.org/W3014478035","https://openalex.org/W3015867569","https://openalex.org/W3128588271","https://openalex.org/W3203242722","https://openalex.org/W4200087860","https://openalex.org/W4205751596","https://openalex.org/W4280500142","https://openalex.org/W4294391354","https://openalex.org/W4312904003","https://openalex.org/W4322627135","https://openalex.org/W4383669900","https://openalex.org/W4401493636"],"related_works":["https://openalex.org/W4412757870","https://openalex.org/W7213110109","https://openalex.org/W3014478035","https://openalex.org/W4400429284","https://openalex.org/W2027357591","https://openalex.org/W7164043300","https://openalex.org/W7170192612","https://openalex.org/W7212142209","https://openalex.org/W3034080524","https://openalex.org/W4390888235"],"abstract_inverted_index":{"Objective:":[0],"The":[1,67,94,110,130,153,175],"primary":[2],"aim":[3],"of":[4,22,54,60,77,105,108,113,167,191],"this":[5],"study":[6],"is":[7,186],"to":[8,159],"develop":[9],"and":[10,15,40,49,82,122,127,143,150,171,185,201],"verify":[11],"a":[12,41,52,57,103],"linear,":[13],"exact,":[14],"specific":[16],"LC-ESI-MS/MS":[17],"technique":[18],"for":[19,80,84,116,120,134,161,188,196],"the":[20,64,73,85,117,162,189],"measurement":[21],"Repotrectinib.":[23],"Methods:":[24],"Chromatographic":[25],"resolution":[26],"was":[27,69,98],"attained":[28],"using":[29],"an":[30],"ODS":[31],"Zorbax":[32],"C18":[33],"column":[34],"(50":[35],"mm\u00d74.6":[36],"mm,":[37],"2.1":[38],"\u00b5m)":[39],"mobile":[42],"phase":[43],"comprising":[44],"methanol,":[45],"0.1%":[46],"formic":[47],"acid,":[48],"acetonitrile":[50],"in":[51,89,180,193],"ratio":[53],"50:15:35,":[55],"with":[56,102,182],"flow":[58],"rate":[59],"0.5":[61],"ml/min":[62],"from":[63,157],"stationary":[65],"phase.":[66],"procedure":[68],"conducted":[70],"by":[71],"observing":[72],"defined":[74],"ionic":[75],"transitions":[76],"m/z":[78],"356.15/318.13":[79],"Repotrectinib":[81,135],"478.09/451.08":[83],"Apalutamide":[86],"internal":[87],"standard":[88],"multiple":[90],"reaction":[91],"monitoring.":[92],"Results:":[93],"linear":[95],"regression":[96],"equation":[97],"y":[99],"=":[100],"0.0001x+0.0012,":[101],"coefficient":[104,112],"determination":[106],"(r\u00b2)":[107],"0.9997.":[109],"percentage":[111],"variation":[114],"results":[115],"matrix":[118],"effect":[119],"Low-QC":[121,144],"High-QC":[123,137],"levels":[124],"were":[125,147],"2.90%":[126],"3.41%,":[128],"respectively.":[129,152],"average":[131],"recovery":[132],"percentages":[133],"at":[136,165],"(11.25":[138],"\u00b5g/ml),":[139,142],"MQC":[140],"(7.50":[141],"(1.05":[145],"\u00b5g/ml)":[146],"103.27%,":[148],"97.26%,":[149],"96.34%,":[151],"measured":[154],"values":[155],"ranged":[156],"2.00%":[158],"4.03%":[160],"QC":[163],"samples":[164,195],"concentrations":[166],"0.375,":[168],"1.05,":[169],"7.50,":[170],"11.25":[172],"\u00b5g/ml.":[173],"Conclusion:":[174],"created":[176],"approach":[177],"underwent":[178],"validation":[179],"accordance":[181],"FDA":[183],"guidelines":[184],"applicable":[187],"assessment":[190],"repotrectinib":[192],"biological":[194],"quality":[197],"control,":[198],"forensic":[199],"analysis,":[200],"bioavailability":[202],"investigations.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-01-20T00:00:00"}